Capricor plunges on FDA AdCom briefing doc for Duchenne treatment
Capricor plunges on FDA AdCom briefing doc for Duchenne treatment Seeking Alpha
Covered in this story
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.